The United States gay-rights organization on Saturday promoted the usage of the pill Truvada. The once-a-day Truvada is found useful in preventing the HIV infection.
The largest gay-rights group in US is demanding that the insurance companies should cover the pill Truvada.
Till now, many doctors were not prescribing Truvada once-a-day pill. It is said that doctors were under the impression that prescribing the pill may lead to unprotected sex, which may further increase the HIV chances.
CDC, WHO and many organizations which provide support to HIV and AIDS infected people has been endorsing the usefulness of this pill for some time now.
The Human Rights organizations, particularly those which are supporting the gay-rights and supporting the supreme court case on same-sex marriage has also joined the chorus to support the usage of Truvada as a preventive measure against HIV virus which may lead to AIDS. The Human Rights groups consider this drug as “a critically important tool” in the fight against HIV.
Truvada was first approved in 2012 by FDA as PrEP (pre-exposure prophylaxis). The basic aim behind the FDA’s approval was to prevent the HIV transmission through sexual contact.
Human Rights Campaign president, Chad Griffin said, “Today, there is an unprecedented chance to end the HIV/AIDS epidemic, in part through PrEP’s aggressive prevention of new HIV infections.” Griffin, who is also associated with the same group supporting to bring in same-sex marriage law also said, “There is no reason — medical or otherwise — to discourage individuals from taking control of their sexual health and talking to their doctor about PrEP.”
CDC has already announced that their research on the drug has shown 90 percent chances of preventing the HIV exposure. The annual International AIDS Conference which held in July has also presented a study according to which the drug even if skipped some day was still effective if the protective measures were taken during the sexual intercourse.
The fact sheet of New York State Health Department estimates the cost of Truvada to be in the range of $8000 to $14000 per year.
Gilead Sciences Inc., the company which manufactures Truvada has recently announced that they has a program which supports the people who are good candidates of Truvada but cannot afford it because of high cost.
CDC reports suggest that every year 50,000 new cases of HIV infections are reported among which gay and bisexual men accounts for 63 percent. Gay rights group advocates that these stats can be reduced if doctors are advised to prescribe the pill and insurers become more generous in covering the cost of the pill Truvada.